In NASH with liver fibrosis, resmetirom improved NASH « metajournal.com

Ann. Intern. Med. · Jun 2024

Randomized Controlled Trial

In NASH with liver fibrosis, resmetirom improved NASH resolution and reduced fibrosis at 1 y.

Harrison SA, Bedossa P, Guy CD, et al. MAESTRO-NASH Investigators. A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis. N Engl J Med. 2024;390:497-509. 38324483.

read more…
- Maria Mironova and Averell H Sherker.
- Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA (M.M.).
- Ann. Intern. Med. 2024 Jun 1; 177 (6): JC63JC63.
AbstractHarrison SA, Bedossa P, Guy CD, et al. MAESTRO-NASH Investigators. A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis. N Engl J Med. 2024;390:497-509. 38324483.

Pubmed Copy Citation

Add institutional full text...

Notes

hide…

Want more great medical articles?

Keep up to date with a free trial of metajournal, personalized for your practice.
1,704,841 articles already indexed!